aluates Reports

$ 0.0

Automative

Global AAV Gene Therapy Injection Market Research Report 2026

Published Date: 2026-01-26

Report Code: QYRE-Auto-34J18296

Global AAV Gene Therapy Injection Market Research Report 2024

BUY CHAPTERS

Global AAV Gene Therapy Injection Market Research Report 2026

Code: QYRE-Auto-34J18296

Report

2026-01-26

Pages:104

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Avexis/Novartis (Zolgensma)

Sarepta Therapeutics (Elevidys)

Spark/Roche (Luxturna)

PTC Therapeutics (Upstaza)

BioMarin (Roctavian)

CSL/uniQure (Hemgenix&Glybera)

Pfizer Inc

Beijing Innovikang (Pipeline)

Suzhou NoJieBeig (Pipeline)

Belief BioMed (Pipeline)

CSL/uniQure (Hemgenix&Glybera)

AAV Gene Therapy Injection Market Size

The global AAV Gene Therapy Injection market was valued at US$ 2531 million in 2025 and is anticipated to reach US$ 12720 million by 2032, at a CAGR of 26.3% from 2026 to 2032.

AAV Gene Therapy Injection Market

AAV gene therapy injection is a biological preparation that contains the adeno - associated virus (AAV) vector. It's designed to deliver specific therapeutic genes into the cells of a patient's body for the treatment of diseases. This injection is a crucial tool in gene therapy and functions through direct injection into human tissues or intravenous infusion. Adeno-associated viruses (AAV) are small viruses that infect humans and some other primate species. They belong to the genus Dependoparvovirus.

The North American market for AAV Gene Therapy Injection is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for AAV Gene Therapy Injection is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The global market for AAV Gene Therapy Injection in Spinal Muscular Atrophy (SMA) is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.

Major global companies of AAV Gene Therapy Injection include Avexis/Novartis (Zolgensma), Sarepta Therapeutics (Elevidys), Spark/Roche (Luxturna), PTC Therapeutics (Upstaza), BioMarin (Roctavian), CSL/uniQure (Hemgenix&Glybera), Pfizer, Beijing Innovikang (Pipeline), Suzhou NoJieBeig (Pipeline), Belief BioMed (Pipeline), etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global AAV Gene Therapy Injection market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding AAV Gene Therapy Injection. The AAV Gene Therapy Injection market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global AAV Gene Therapy Injection market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist AAV Gene Therapy Injection manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of AAV Gene Therapy Injection Market Report

Report Metric	Details
Report Name	AAV Gene Therapy Injection Market
Accounted market size in 2025	US$ 2531 million
Forecasted market size in 2032	US$ 12720 million
CAGR	26.3%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	scAAV9 Vector AVV2 Vector AVV5 Vector AAVrh74 Vector
Segment by Application	Spinal Muscular Atrophy (SMA) Ophthalmic Diseases Hemophilia Duchenne Muscular Dystrophy (DMD) Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Avexis/Novartis (Zolgensma), Sarepta Therapeutics (Elevidys), Spark/Roche (Luxturna), PTC Therapeutics (Upstaza), BioMarin (Roctavian), CSL/uniQure (Hemgenix&Glybera), Pfizer, Beijing Innovikang (Pipeline), Suzhou NoJieBeig (Pipeline), Belief BioMed (Pipeline)
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for AAV Gene Therapy Injection companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is AAV Gene Therapy Injection Market growing?

Ans: The AAV Gene Therapy Injection Market witnessing a CAGR of 26.3% during the forecast period 2026-2032.

What is the AAV Gene Therapy Injection Market size in 2032?

Ans: The AAV Gene Therapy Injection Market size in 2032 will be US$ 12720 million.

Who are the main players in the AAV Gene Therapy Injection Market report?

Ans: The main players in the AAV Gene Therapy Injection Market are Avexis/Novartis (Zolgensma), Sarepta Therapeutics (Elevidys), Spark/Roche (Luxturna), PTC Therapeutics (Upstaza), BioMarin (Roctavian), CSL/uniQure (Hemgenix&Glybera), Pfizer, Beijing Innovikang (Pipeline), Suzhou NoJieBeig (Pipeline), Belief BioMed (Pipeline)

What are the Application segmentation covered in the AAV Gene Therapy Injection Market report?

Ans: The Applications covered in the AAV Gene Therapy Injection Market report are Spinal Muscular Atrophy (SMA), Ophthalmic Diseases, Hemophilia, Duchenne Muscular Dystrophy (DMD), Others

What are the Type segmentation covered in the AAV Gene Therapy Injection Market report?

Ans: The Types covered in the AAV Gene Therapy Injection Market report are scAAV9 Vector, AVV2 Vector, AVV5 Vector, AAVrh74 Vector

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global AAV Gene Therapy Injection Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 scAAV9 Vector

1.2.3 AVV2 Vector

1.2.4 AVV5 Vector

1.2.5 AAVrh74 Vector

1.3 Market by Application

1.3.1 Global AAV Gene Therapy Injection Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Spinal Muscular Atrophy (SMA)

1.3.3 Ophthalmic Diseases

1.3.4 Hemophilia

1.3.5 Duchenne Muscular Dystrophy (DMD)

1.3.6 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global AAV Gene Therapy Injection Market Perspective (2021–2032)

2.2 Global AAV Gene Therapy Injection Growth Trends by Region

2.2.1 Global AAV Gene Therapy Injection Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 AAV Gene Therapy Injection Historic Market Size by Region (2021–2026)

2.2.3 AAV Gene Therapy Injection Forecasted Market Size by Region (2027–2032)

2.3 AAV Gene Therapy Injection Market Dynamics

2.3.1 AAV Gene Therapy Injection Industry Trends

2.3.2 AAV Gene Therapy Injection Market Drivers

2.3.3 AAV Gene Therapy Injection Market Challenges

2.3.4 AAV Gene Therapy Injection Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top AAV Gene Therapy Injection Players by Revenue

3.1.1 Global Top AAV Gene Therapy Injection Players by Revenue (2021–2026)

3.1.2 Global AAV Gene Therapy Injection Revenue Market Share by Players (2021–2026)

3.2 Global Top AAV Gene Therapy Injection Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by AAV Gene Therapy Injection Revenue

3.4 Global AAV Gene Therapy Injection Market Concentration Ratio

3.4.1 Global AAV Gene Therapy Injection Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by AAV Gene Therapy Injection Revenue in 2025

3.5 Global Key Players of AAV Gene Therapy Injection Head Offices and Areas Served

3.6 Global Key Players of AAV Gene Therapy Injection, Products and Applications

3.7 Global Key Players of AAV Gene Therapy Injection, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 AAV Gene Therapy Injection Breakdown Data by Type

4.1 Global AAV Gene Therapy Injection Historic Market Size by Type (2021–2026)

4.2 Global AAV Gene Therapy Injection Forecasted Market Size by Type (2027–2032)

5 AAV Gene Therapy Injection Breakdown Data by Application

5.1 Global AAV Gene Therapy Injection Historic Market Size by Application (2021–2026)

5.2 Global AAV Gene Therapy Injection Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America AAV Gene Therapy Injection Market Size (2021–2032)

6.2 North America AAV Gene Therapy Injection Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America AAV Gene Therapy Injection Market Size by Country (2021–2026)

6.4 North America AAV Gene Therapy Injection Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe AAV Gene Therapy Injection Market Size (2021–2032)

7.2 Europe AAV Gene Therapy Injection Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe AAV Gene Therapy Injection Market Size by Country (2021–2026)

7.4 Europe AAV Gene Therapy Injection Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific AAV Gene Therapy Injection Market Size (2021–2032)

8.2 Asia-Pacific AAV Gene Therapy Injection Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific AAV Gene Therapy Injection Market Size by Region (2021–2026)

8.4 Asia-Pacific AAV Gene Therapy Injection Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America AAV Gene Therapy Injection Market Size (2021–2032)

9.2 Latin America AAV Gene Therapy Injection Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America AAV Gene Therapy Injection Market Size by Country (2021–2026)

9.4 Latin America AAV Gene Therapy Injection Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa AAV Gene Therapy Injection Market Size (2021–2032)

10.2 Middle East & Africa AAV Gene Therapy Injection Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa AAV Gene Therapy Injection Market Size by Country (2021–2026)

10.4 Middle East & Africa AAV Gene Therapy Injection Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Avexis/Novartis (Zolgensma)

11.1.1 Avexis/Novartis (Zolgensma) Company Details

11.1.2 Avexis/Novartis (Zolgensma) Business Overview

11.1.3 Avexis/Novartis (Zolgensma) AAV Gene Therapy Injection Introduction

11.1.4 Avexis/Novartis (Zolgensma) Revenue in AAV Gene Therapy Injection Business (2021–2026)

11.1.5 Avexis/Novartis (Zolgensma) Recent Development

11.2 Sarepta Therapeutics (Elevidys)

11.2.1 Sarepta Therapeutics (Elevidys) Company Details

11.2.2 Sarepta Therapeutics (Elevidys) Business Overview

11.2.3 Sarepta Therapeutics (Elevidys) AAV Gene Therapy Injection Introduction

11.2.4 Sarepta Therapeutics (Elevidys) Revenue in AAV Gene Therapy Injection Business (2021–2026)

11.2.5 Sarepta Therapeutics (Elevidys) Recent Development

11.3 Spark/Roche (Luxturna)

11.3.1 Spark/Roche (Luxturna) Company Details

11.3.2 Spark/Roche (Luxturna) Business Overview

11.3.3 Spark/Roche (Luxturna) AAV Gene Therapy Injection Introduction

11.3.4 Spark/Roche (Luxturna) Revenue in AAV Gene Therapy Injection Business (2021–2026)

11.3.5 Spark/Roche (Luxturna) Recent Development

11.4 PTC Therapeutics (Upstaza)

11.4.1 PTC Therapeutics (Upstaza) Company Details

11.4.2 PTC Therapeutics (Upstaza) Business Overview

11.4.3 PTC Therapeutics (Upstaza) AAV Gene Therapy Injection Introduction

11.4.4 PTC Therapeutics (Upstaza) Revenue in AAV Gene Therapy Injection Business (2021–2026)

11.4.5 PTC Therapeutics (Upstaza) Recent Development

11.5 BioMarin (Roctavian)

11.5.1 BioMarin (Roctavian) Company Details

11.5.2 BioMarin (Roctavian) Business Overview

11.5.3 BioMarin (Roctavian) AAV Gene Therapy Injection Introduction

11.5.4 BioMarin (Roctavian) Revenue in AAV Gene Therapy Injection Business (2021–2026)

11.5.5 BioMarin (Roctavian) Recent Development

11.6 CSL/uniQure (Hemgenix&Glybera)

11.6.1 CSL/uniQure (Hemgenix&Glybera) Company Details

11.6.2 CSL/uniQure (Hemgenix&Glybera) Business Overview

11.6.3 CSL/uniQure (Hemgenix&Glybera) AAV Gene Therapy Injection Introduction

11.6.4 CSL/uniQure (Hemgenix&Glybera) Revenue in AAV Gene Therapy Injection Business (2021–2026)

11.6.5 CSL/uniQure (Hemgenix&Glybera) Recent Development

11.7 Pfizer

11.7.1 Pfizer Company Details

11.7.2 Pfizer Business Overview

11.7.3 Pfizer AAV Gene Therapy Injection Introduction

11.7.4 Pfizer Revenue in AAV Gene Therapy Injection Business (2021–2026)

11.7.5 Pfizer Recent Development

11.8 Beijing Innovikang (Pipeline)

11.8.1 Beijing Innovikang (Pipeline) Company Details

11.8.2 Beijing Innovikang (Pipeline) Business Overview

11.8.3 Beijing Innovikang (Pipeline) AAV Gene Therapy Injection Introduction

11.8.4 Beijing Innovikang (Pipeline) Revenue in AAV Gene Therapy Injection Business (2021–2026)

11.8.5 Beijing Innovikang (Pipeline) Recent Development

11.9 Suzhou NoJieBeig (Pipeline)

11.9.1 Suzhou NoJieBeig (Pipeline) Company Details

11.9.2 Suzhou NoJieBeig (Pipeline) Business Overview

11.9.3 Suzhou NoJieBeig (Pipeline) AAV Gene Therapy Injection Introduction

11.9.4 Suzhou NoJieBeig (Pipeline) Revenue in AAV Gene Therapy Injection Business (2021–2026)

11.9.5 Suzhou NoJieBeig (Pipeline) Recent Development

11.10 Belief BioMed (Pipeline)

11.10.1 Belief BioMed (Pipeline) Company Details

11.10.2 Belief BioMed (Pipeline) Business Overview

11.10.3 Belief BioMed (Pipeline) AAV Gene Therapy Injection Introduction

11.10.4 Belief BioMed (Pipeline) Revenue in AAV Gene Therapy Injection Business (2021–2026)

11.10.5 Belief BioMed (Pipeline) Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Avexis/Novartis (Zolgensma)

Sarepta Therapeutics (Elevidys)

Spark/Roche (Luxturna)

PTC Therapeutics (Upstaza)

BioMarin (Roctavian)

CSL/uniQure (Hemgenix&Glybera)

Pfizer Inc

Beijing Innovikang (Pipeline)

Suzhou NoJieBeig (Pipeline)

Belief BioMed (Pipeline)

CSL/uniQure (Hemgenix&Glybera)

List of Tables

Table 1. Global AAV Gene Therapy Injection Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of scAAV9 Vector

Table 3. Key Players of AVV2 Vector

Table 4. Key Players of AVV5 Vector

Table 5. Key Players of AAVrh74 Vector

Table 6. Global AAV Gene Therapy Injection Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 7. Global AAV Gene Therapy Injection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 8. Global AAV Gene Therapy Injection Market Size by Region (US$ Million), 2021–2026

Table 9. Global AAV Gene Therapy Injection Market Share by Region (2021–2026)

Table 10. Global AAV Gene Therapy Injection Forecasted Market Size by Region (US$ Million), 2027–2032

Table 11. Global AAV Gene Therapy Injection Market Share by Region (2027–2032)

Table 12. AAV Gene Therapy Injection Market Trends

Table 13. AAV Gene Therapy Injection Market Drivers

Table 14. AAV Gene Therapy Injection Market Challenges

Table 15. AAV Gene Therapy Injection Market Restraints

Table 16. Global AAV Gene Therapy Injection Revenue by Players (US$ Million), 2021–2026

Table 17. Global AAV Gene Therapy Injection Market Share by Players (2021–2026)

Table 18. Global Top AAV Gene Therapy Injection Players by Tier (Tier 1, Tier 2, and Tier 3), based on AAV Gene Therapy Injection Revenue, 2025

Table 19. Ranking of Global Top AAV Gene Therapy Injection Companies by Revenue (US$ Million) in 2025

Table 20. Global 5 Largest Players Market Share by AAV Gene Therapy Injection Revenue (CR5 and HHI), 2021–2026

Table 21. Global Key Players of AAV Gene Therapy Injection, Headquarters and Area Served

Table 22. Global Key Players of AAV Gene Therapy Injection, Products and Applications

Table 23. Global Key Players of AAV Gene Therapy Injection, Date of General Availability (GA)

Table 24. Mergers and Acquisitions, Expansion Plans

Table 25. Global AAV Gene Therapy Injection Market Size by Type (US$ Million), 2021–2026

Table 26. Global AAV Gene Therapy Injection Revenue Market Share by Type (2021–2026)

Table 27. Global AAV Gene Therapy Injection Forecasted Market Size by Type (US$ Million), 2027–2032

Table 28. Global AAV Gene Therapy Injection Revenue Market Share by Type (2027–2032)

Table 29. Global AAV Gene Therapy Injection Market Size by Application (US$ Million), 2021–2026

Table 30. Global AAV Gene Therapy Injection Revenue Market Share by Application (2021–2026)

Table 31. Global AAV Gene Therapy Injection Forecasted Market Size by Application (US$ Million), 2027–2032

Table 32. Global AAV Gene Therapy Injection Revenue Market Share by Application (2027–2032)

Table 33. North America AAV Gene Therapy Injection Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 34. North America AAV Gene Therapy Injection Market Size by Country (US$ Million), 2021–2026

Table 35. North America AAV Gene Therapy Injection Market Size by Country (US$ Million), 2027–2032

Table 36. Europe AAV Gene Therapy Injection Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 37. Europe AAV Gene Therapy Injection Market Size by Country (US$ Million), 2021–2026

Table 38. Europe AAV Gene Therapy Injection Market Size by Country (US$ Million), 2027–2032

Table 39. Asia-Pacific AAV Gene Therapy Injection Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 40. Asia-Pacific AAV Gene Therapy Injection Market Size by Region (US$ Million), 2021–2026

Table 41. Asia-Pacific AAV Gene Therapy Injection Market Size by Region (US$ Million), 2027–2032

Table 42. Latin America AAV Gene Therapy Injection Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 43. Latin America AAV Gene Therapy Injection Market Size by Country (US$ Million), 2021–2026

Table 44. Latin America AAV Gene Therapy Injection Market Size by Country (US$ Million), 2027–2032

Table 45. Middle East & Africa AAV Gene Therapy Injection Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 46. Middle East & Africa AAV Gene Therapy Injection Market Size by Country (US$ Million), 2021–2026

Table 47. Middle East & Africa AAV Gene Therapy Injection Market Size by Country (US$ Million), 2027–2032

Table 48. Avexis/Novartis (Zolgensma) Company Details

Table 49. Avexis/Novartis (Zolgensma) Business Overview

Table 50. Avexis/Novartis (Zolgensma) AAV Gene Therapy Injection Product

Table 51. Avexis/Novartis (Zolgensma) Revenue in AAV Gene Therapy Injection Business (US$ Million), 2021–2026

Table 52. Avexis/Novartis (Zolgensma) Recent Development

Table 53. Sarepta Therapeutics (Elevidys) Company Details

Table 54. Sarepta Therapeutics (Elevidys) Business Overview

Table 55. Sarepta Therapeutics (Elevidys) AAV Gene Therapy Injection Product

Table 56. Sarepta Therapeutics (Elevidys) Revenue in AAV Gene Therapy Injection Business (US$ Million), 2021–2026

Table 57. Sarepta Therapeutics (Elevidys) Recent Development

Table 58. Spark/Roche (Luxturna) Company Details

Table 59. Spark/Roche (Luxturna) Business Overview

Table 60. Spark/Roche (Luxturna) AAV Gene Therapy Injection Product

Table 61. Spark/Roche (Luxturna) Revenue in AAV Gene Therapy Injection Business (US$ Million), 2021–2026

Table 62. Spark/Roche (Luxturna) Recent Development

Table 63. PTC Therapeutics (Upstaza) Company Details

Table 64. PTC Therapeutics (Upstaza) Business Overview

Table 65. PTC Therapeutics (Upstaza) AAV Gene Therapy Injection Product

Table 66. PTC Therapeutics (Upstaza) Revenue in AAV Gene Therapy Injection Business (US$ Million), 2021–2026

Table 67. PTC Therapeutics (Upstaza) Recent Development

Table 68. BioMarin (Roctavian) Company Details

Table 69. BioMarin (Roctavian) Business Overview

Table 70. BioMarin (Roctavian) AAV Gene Therapy Injection Product

Table 71. BioMarin (Roctavian) Revenue in AAV Gene Therapy Injection Business (US$ Million), 2021–2026

Table 72. BioMarin (Roctavian) Recent Development

Table 73. CSL/uniQure (Hemgenix&Glybera) Company Details

Table 74. CSL/uniQure (Hemgenix&Glybera) Business Overview

Table 75. CSL/uniQure (Hemgenix&Glybera) AAV Gene Therapy Injection Product

Table 76. CSL/uniQure (Hemgenix&Glybera) Revenue in AAV Gene Therapy Injection Business (US$ Million), 2021–2026

Table 77. CSL/uniQure (Hemgenix&Glybera) Recent Development

Table 78. Pfizer Company Details

Table 79. Pfizer Business Overview

Table 80. Pfizer AAV Gene Therapy Injection Product

Table 81. Pfizer Revenue in AAV Gene Therapy Injection Business (US$ Million), 2021–2026

Table 82. Pfizer Recent Development

Table 83. Beijing Innovikang (Pipeline) Company Details

Table 84. Beijing Innovikang (Pipeline) Business Overview

Table 85. Beijing Innovikang (Pipeline) AAV Gene Therapy Injection Product

Table 86. Beijing Innovikang (Pipeline) Revenue in AAV Gene Therapy Injection Business (US$ Million), 2021–2026

Table 87. Beijing Innovikang (Pipeline) Recent Development

Table 88. Suzhou NoJieBeig (Pipeline) Company Details

Table 89. Suzhou NoJieBeig (Pipeline) Business Overview

Table 90. Suzhou NoJieBeig (Pipeline) AAV Gene Therapy Injection Product

Table 91. Suzhou NoJieBeig (Pipeline) Revenue in AAV Gene Therapy Injection Business (US$ Million), 2021–2026

Table 92. Suzhou NoJieBeig (Pipeline) Recent Development

Table 93. Belief BioMed (Pipeline) Company Details

Table 94. Belief BioMed (Pipeline) Business Overview

Table 95. Belief BioMed (Pipeline) AAV Gene Therapy Injection Product

Table 96. Belief BioMed (Pipeline) Revenue in AAV Gene Therapy Injection Business (US$ Million), 2021–2026

Table 97. Belief BioMed (Pipeline) Recent Development

Table 98. Research Programs/Design for This Report

Table 99. Key Data Information from Secondary Sources

Table 100. Key Data Information from Primary Sources

Table 101. Authors List of This Report

List of Figures

Figure 1. AAV Gene Therapy Injection Picture

Figure 2. Global AAV Gene Therapy Injection Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global AAV Gene Therapy Injection Market Share by Type: 2025 vs 2032

Figure 4. scAAV9 Vector Features

Figure 5. AVV2 Vector Features

Figure 6. AVV5 Vector Features

Figure 7. AAVrh74 Vector Features

Figure 8. Global AAV Gene Therapy Injection Market Size by Application (US$ Million), 2021–2032

Figure 9. Global AAV Gene Therapy Injection Market Share by Application: 2025 vs 2032

Figure 10. Spinal Muscular Atrophy (SMA) Case Studies

Figure 11. Ophthalmic Diseases Case Studies

Figure 12. Hemophilia Case Studies

Figure 13. Duchenne Muscular Dystrophy (DMD) Case Studies

Figure 14. Others Case Studies

Figure 15. AAV Gene Therapy Injection Report Years Considered

Figure 16. Global AAV Gene Therapy Injection Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 17. Global AAV Gene Therapy Injection Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 18. Global AAV Gene Therapy Injection Market Share by Region: 2025 vs 2032

Figure 19. Global AAV Gene Therapy Injection Market Share by Players in 2025

Figure 20. Global AAV Gene Therapy Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 21. The Top 10 and 5 Players Market Share by AAV Gene Therapy Injection Revenue in 2025

Figure 22. North America AAV Gene Therapy Injection Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. North America AAV Gene Therapy Injection Market Share by Country (2021–2032)

Figure 24. United States AAV Gene Therapy Injection Market Size YoY Growth (US$ Million), 2021–2032

Figure 25. Canada AAV Gene Therapy Injection Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. Europe AAV Gene Therapy Injection Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. Europe AAV Gene Therapy Injection Market Share by Country (2021–2032)

Figure 28. Germany AAV Gene Therapy Injection Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. France AAV Gene Therapy Injection Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. U.K. AAV Gene Therapy Injection Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Italy AAV Gene Therapy Injection Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Russia AAV Gene Therapy Injection Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Ireland AAV Gene Therapy Injection Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Asia-Pacific AAV Gene Therapy Injection Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. Asia-Pacific AAV Gene Therapy Injection Market Share by Region (2021–2032)

Figure 36. China AAV Gene Therapy Injection Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Japan AAV Gene Therapy Injection Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. South Korea AAV Gene Therapy Injection Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Southeast Asia AAV Gene Therapy Injection Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. India AAV Gene Therapy Injection Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Australia & New Zealand AAV Gene Therapy Injection Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Latin America AAV Gene Therapy Injection Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Latin America AAV Gene Therapy Injection Market Share by Country (2021–2032)

Figure 44. Mexico AAV Gene Therapy Injection Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Brazil AAV Gene Therapy Injection Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Middle East & Africa AAV Gene Therapy Injection Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Middle East & Africa AAV Gene Therapy Injection Market Share by Country (2021–2032)

Figure 48. Israel AAV Gene Therapy Injection Market Size YoY Growth (US$ Million), 2021–2032

Figure 49. Saudi Arabia AAV Gene Therapy Injection Market Size YoY Growth (US$ Million), 2021–2032

Figure 50. UAE AAV Gene Therapy Injection Market Size YoY Growth (US$ Million), 2021–2032

Figure 51. Avexis/Novartis (Zolgensma) Revenue Growth Rate in AAV Gene Therapy Injection Business (2021–2026)

Figure 52. Sarepta Therapeutics (Elevidys) Revenue Growth Rate in AAV Gene Therapy Injection Business (2021–2026)

Figure 53. Spark/Roche (Luxturna) Revenue Growth Rate in AAV Gene Therapy Injection Business (2021–2026)

Figure 54. PTC Therapeutics (Upstaza) Revenue Growth Rate in AAV Gene Therapy Injection Business (2021–2026)

Figure 55. BioMarin (Roctavian) Revenue Growth Rate in AAV Gene Therapy Injection Business (2021–2026)

Figure 56. CSL/uniQure (Hemgenix&Glybera) Revenue Growth Rate in AAV Gene Therapy Injection Business (2021–2026)

Figure 57. Pfizer Revenue Growth Rate in AAV Gene Therapy Injection Business (2021–2026)

Figure 58. Beijing Innovikang (Pipeline) Revenue Growth Rate in AAV Gene Therapy Injection Business (2021–2026)

Figure 59. Suzhou NoJieBeig (Pipeline) Revenue Growth Rate in AAV Gene Therapy Injection Business (2021–2026)

Figure 60. Belief BioMed (Pipeline) Revenue Growth Rate in AAV Gene Therapy Injection Business (2021–2026)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global AAV Vector Gene Therapy Market Research Report 2024

Global AAV based Gene Therapy Products Market Research Report 2024

Global AAV Vector Based Gene Therapy Drugs Market Research Report 2024

Global Adeno Associated Virus Vectors in Gene Therapy Market Research Report 2025

Adeno Associated Virus AAV Vector Based Gene Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Ophthalmic AAV Gene Therapy Market Research Report 2024

Global AAV Transfection Reagent Market Research Report 2024

Global Custom Adeno Associated Virus AAV Services Market Research Report 2024

Global Gene based Advanced Therapy Medicinal Market Research Report 2025

Global Gene based Therapy Medicinal Market Research Report 2024

Global Gene Delivery or Gene Therapy Drug Market Research Report 2025

Global Adeno Associated Virus AAV Packaging Service Market Research Report 2024

Global Gene Therapy Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031

Adeno Associated Virus AAV Gene Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Viral Vectors Gene Therapy Market Research Report 2025

Adeno associated Virus Packaging Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Hemophilia AAV Gene Therapy Market Research Report 2024

Global Human Gene Therapy Market Research Report 2025

Global Gene Therapies for Cancer Treatment Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions